These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 36636094)
21. Survival outcomes of stage I colorectal cancer: development and validation of the ACEPLY model using two prospective cohorts. Wu Q; Chen P; Shu C; Chen L; Jin Z; Huang J; Wang X; Li X; Wei M; Yang T; Deng X; Wu A; He Y; Wang Z BMC Med; 2023 Jan; 21(1):3. PubMed ID: 36600277 [TBL] [Abstract][Full Text] [Related]
22. Clinical implications of perineural invasion in patients with colorectal cancer. Hu G; Li L; Hu K Medicine (Baltimore); 2020 Apr; 99(17):e19860. PubMed ID: 32332645 [TBL] [Abstract][Full Text] [Related]
23. Clinical significance of perineural invasion in stages II and III colorectal cancer. Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129 [TBL] [Abstract][Full Text] [Related]
24. A predictive model and rapid multi-dynamic algorithm developed based on tumor-stroma percentage in gastric cancer: a retrospective, observational study. Xu Y; Yang Y; Cheng F; Luo Z; Zhang Y; Zhang P; Qiu J; Qiu Z; Huang C Gastroenterol Rep (Oxf); 2024; 12():goae083. PubMed ID: 39399262 [TBL] [Abstract][Full Text] [Related]
25. Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study. Ran X; Chen Y; Liu C; Xiao H; Su X; Chen Z; Du J; He J; Zhong P; Li M; Dai N; Chen C J Gastrointest Oncol; 2024 Aug; 15(4):1545-1555. PubMed ID: 39279933 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
27. Clinical value and application of a novel nomogram containing inflammatory, nutritional and clinical markers in predicting overall survival of stage II/III gastric cancer patients after radical resection: a bi-centered retrospective study of 2,443 patients. Liang S; Wei C; Tang L; Gao J; Yan W; Wu J; Long Z; Wang Y Am J Transl Res; 2022; 14(7):5107-5115. PubMed ID: 35958492 [TBL] [Abstract][Full Text] [Related]
28. Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases. Zhai Y; Bai W; Zhou J; Dong Q; Zhang J BMC Cancer; 2022 Jan; 22(1):103. PubMed ID: 35078439 [TBL] [Abstract][Full Text] [Related]
29. Novel Internationally Verified Method Reports Desmoplastic Reaction as the Most Significant Prognostic Feature For Disease-specific Survival in Stage II Colorectal Cancer. Nearchou IP; Kajiwara Y; Mochizuki S; Harrison DJ; Caie PD; Ueno H Am J Surg Pathol; 2019 Sep; 43(9):1239-1248. PubMed ID: 31206364 [TBL] [Abstract][Full Text] [Related]
30. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis. Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670 [TBL] [Abstract][Full Text] [Related]
31. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach. Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494 [TBL] [Abstract][Full Text] [Related]
32. Significance of desmoplastic reactions on tumor deposits in patients with colorectal cancer. Kobayashi T; Ishida M; Miki H; Hatta M; Hamada M; Hirose Y; Sekimoto M Oncol Lett; 2023 Jan; 25(1):1. PubMed ID: 36419753 [TBL] [Abstract][Full Text] [Related]
33. Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review. Gao J; Shen Z; Deng Z; Mei L Front Oncol; 2021; 11():738080. PubMed ID: 34868930 [TBL] [Abstract][Full Text] [Related]
34. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242 [TBL] [Abstract][Full Text] [Related]
35. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery. Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M; JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003 [TBL] [Abstract][Full Text] [Related]
36. Development of a New Recurrence-Free Survival Prediction Nomogram for Patients with Primary Non-Muscle-Invasive Bladder Cancer Based on Preoperative Controlling Nutritional Status Score. Zhao L; Sun J; Wang K; Tai S; Hua R; Yu Y; Fan Y; Huang J Cancer Manag Res; 2021; 13():6473-6487. PubMed ID: 34429654 [TBL] [Abstract][Full Text] [Related]
37. Immature Stroma and Prognostic Profiling in Colorectal Carcinoma: Development and Validation of Novel Classification Systems. Hacking S; Ebare K; Angert M; Lee L; Vitkovski T; Thomas R; Chavarria H; Jin C; Nasim M Pathol Res Pract; 2020 Jul; 216(7):152970. PubMed ID: 32534718 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer. Li X; Xiong Z; Xie M; Huang Q; Jin L; Yin S; Chen S; Lan P; Lian L J Gastrointest Oncol; 2021 Aug; 12(4):1470-1481. PubMed ID: 34532103 [TBL] [Abstract][Full Text] [Related]
39. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer. Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240 [TBL] [Abstract][Full Text] [Related]
40. Preoperative Neutrophil-BMI Ratio As a Promising New Marker for Predicting Tumor Outcomes in Colorectal Cancer. Xie W; Huang X; Wei C; Mo X; Ru H; Zhang L; Ge L; Tang W; Liu J Technol Cancer Res Treat; 2022; 21():15330338211064077. PubMed ID: 35225701 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]